BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 180 filers reported holding BRIDGEBIO PHARMA INC in Q4 2022. The put-call ratio across all filers is 0.41 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $123 | -62.0% | 4,656 | -76.2% | 0.00% | -75.0% |
| Q1 2023 | $324 | -99.8% | 19,545 | -8.3% | 0.00% | +33.3% |
| Q3 2022 | $212,000 | -80.9% | 21,316 | -82.6% | 0.00% | -75.0% |
| Q2 2022 | $1,111,000 | +263.1% | 122,311 | +305.9% | 0.01% | +500.0% |
| Q1 2022 | $306,000 | +29.1% | 30,134 | +112.3% | 0.00% | +100.0% |
| Q4 2021 | $237,000 | -80.1% | 14,195 | -44.0% | 0.00% | -83.3% |
| Q3 2021 | $1,188,000 | +4.3% | 25,337 | +35.6% | 0.01% | +20.0% |
| Q2 2021 | $1,139,000 | +27.5% | 18,680 | +28.9% | 0.01% | 0.0% |
| Q1 2021 | $893,000 | -32.2% | 14,495 | -21.8% | 0.01% | -28.6% |
| Q4 2020 | $1,318,000 | +131.6% | 18,532 | +22.3% | 0.01% | +75.0% |
| Q3 2020 | $569,000 | -13.7% | 15,158 | -25.0% | 0.00% | -20.0% |
| Q2 2020 | $659,000 | +53.6% | 20,198 | +36.5% | 0.01% | +25.0% |
| Q1 2020 | $429,000 | +123.4% | 14,792 | +170.0% | 0.00% | +100.0% |
| Q4 2019 | $192,000 | -59.7% | 5,478 | -69.0% | 0.00% | -33.3% |
| Q2 2019 | $476,000 | – | 17,647 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 6,068,125 | $160,016,456 | 65.94% |
| Kohlberg Kravis Roberts & Co. L.P. | 31,060,971 | $819,077,805 | 28.79% |
| Cormorant Asset Management, LP | 4,662,530 | $122,950,916 | 7.17% |
| Frazier Life Sciences Management, L.P. | 2,725,949 | $71,883,275 | 4.77% |
| Octagon Capital Advisors LP | 971,639 | $25,622,120 | 3.94% |
| M28 Capital Management LP | 121,200 | $3,196,044 | 3.66% |
| VIKING GLOBAL INVESTORS LP | 25,120,991 | $662,440,533 | 2.69% |
| BOONE CAPITAL MANAGEMENT LLC | 313,381 | $8,263,857 | 2.61% |
| Fernwood Investment Management, LLC | 235,620 | $6,213,299 | 2.23% |
| SOUTHPORT MANAGEMENT, L.L.C. | 15,000 | $395,550 | 2.15% |